These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34653021)

  • 1. Polycystic Ovarian Syndrome Treated with Individualized Homeopathy: A Case Report.
    Lamba P; Sharma D; Sinnarkar VV
    Altern Ther Health Med; 2022 Sep; 28(6):60-64. PubMed ID: 34653021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H; Tanir HM; Yildiz Z
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Female Pelvic Conditions: Polycystic Ovary Syndrome.
    Wilkinson LD; Brady PH; Gin GT; Rosenblum E
    FP Essent; 2022 Apr; 515():26-31. PubMed ID: 35420404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperandrogenism.
    Yadav V; Sharma Y
    Indian J Pediatr; 2023 Oct; 90(10):1018-1024. PubMed ID: 37402107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case Report of Alopecia Areata Treated with Individualized Homoeopathy.
    Bhasme A; Lamba P; Sajjan U
    Altern Ther Health Med; 2023 Apr; 29(3):92-96. PubMed ID: 34653026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approach to polycystic ovary syndrome and other forms of anovulatory infertility.
    Laven JS; Imani B; Eijkemans MJ; Fauser BC
    Obstet Gynecol Surv; 2002 Nov; 57(11):755-67. PubMed ID: 12447098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescence and polycystic ovary syndrome: current concepts on diagnosis and treatment.
    Spritzer PM; Motta AB
    Int J Clin Pract; 2015 Nov; 69(11):1236-46. PubMed ID: 26289303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and acne.
    Chuan SS; Chang RJ
    Skin Therapy Lett; 2010; 15(10):1-4. PubMed ID: 21076799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones for the therapeutic management of polycystic ovary syndrome : impact on metabolic and reproductive abnormalities.
    Elkind-Hirsch KE
    Treat Endocrinol; 2006; 5(3):171-87. PubMed ID: 16677059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report of Alopecia Areata Treated With Individualized Homoeopathy.
    Lamba P; Bhasme A; Kumar A
    Altern Ther Health Med; 2023 Nov; 29(8):478-481. PubMed ID: 37883772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperandrogenic Anovulation: Differential Diagnosis and Evaluation.
    Wierman ME
    Endocrinol Metab Clin North Am; 2021 Mar; 50(1):1-10. PubMed ID: 33518178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinological markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria.
    Mueller A; Dittrich R; Binder H; Hoffmann I; Beckmann MW; Cupisti S
    Eur J Med Res; 2006 Dec; 11(12):540-4. PubMed ID: 17182367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
    Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
    JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?
    Sjaarda LA; Mumford SL; Kissell K; Schliep KC; Hammoud AO; Perkins NJ; Weck J; Wactawski-Wende J; Schisterman EF
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2208-16. PubMed ID: 24606085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome.
    Goudas VT; Dumesic DA
    Endocrinol Metab Clin North Am; 1997 Dec; 26(4):893-912. PubMed ID: 9429864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes.
    Layacha SY; Biswas DA
    Cureus; 2023 Jan; 15(1):e33390. PubMed ID: 36751233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female pattern hair loss and polycystic ovarian syndrome: more than just hirsutism.
    Jiang VS; Hawkins SD; McMichael A
    Curr Opin Endocrinol Diabetes Obes; 2022 Dec; 29(6):535-540. PubMed ID: 36226726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.